INTRODUCTION: The study presents the results of the genomic surveillance of invasive meningococcal disease (IMD) in the Czech Republic for the period of 2015-2017. MATERIAL AND METHODS: The study set includes all available IMD isolates recovered in the Czech Republic and referred to the National Reference Laboratory for Meningococcal Infections in 2015-2017, a total of 89 Neissseria meningitidis isolates-from 2015 (n = 20), 2016 (n = 27), and from 2017 (n = 42). All isolates were studied by whole genome sequencing (WGS). RESULTS: Serogroup B (MenB) was the most common, followed by serogroups C, W, and Y. Altogether 17 clonal complexes were identified, the most common of which was hypervirulent complex cc11, followed by complexes cc32, cc41/44, cc269, and cc865. Over the three study years, hypervirulent cc11 (MenC) showed an upward trend. The WGS method showed two clearly differentiated clusters of N. meningitidis C: P1.5,2:F3-3:ST-11 (cc11). The first cluster is represented by nine isolates, all of which are from 2017. The second cluster consisted of five isolates from 2016 and eight isolates from 2017. Their genetic discordance is illustrated by the changing nadA allele and subsequently by the variance in BAST type. Clonal complex cc269 (MenB) also increased over the time frame. WGS identified the presence of MenB vaccine antigen genes in all B and non-B isolates of N. meningitidis. Altogether 49 different Bexsero antigen sequence types (BAST) were identified and 10 combinations of these have not been previously described in the PubMLST database. CONCLUSIONS: The genomic surveillance of IMD in the Czech Republic provides data needed to update immunisation guidelines for this disease. WGS showed a higher discrimination power and provided more accurate data on molecular characteristics and genetic relationships among invasive N. meningitidis isolates.

National Reference Laboratory for Meningococcal Infections Centre for Epidemiology and Microbiology National Institute of Public Health Prague Czech Republic

Zobrazit více v PubMed

Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, et al. The epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017; 35(16):2034–41. 10.1016/j.vaccine.2017.03.007 PubMed DOI

Revez J, Espinosa L, Albiger B, Leitmeyer KC, Struelens MJ, ECDC National Microbiology Focal Points and Experts Group. Survey on the Use of Whole-Genome Sequencing for Infectious Diseases Surveillance: Rapid Expansion of European National Capacities, 2015–2016. Front Public Health. 2017; 5:347 10.3389/fpubh.2017.00347 PubMed DOI PMC

Eriksson L, Hedberg ST, Jacobsson S, Fredlund H, Mölling P, Stenmark B. Whole-Genome Sequencing of Emerging Invasive Neisseria meningitidis Serogroup W in Sweden. J Clin Microbiol. 2018; 56(4):e01409–17. 10.1128/JCM.01409-17 PubMed DOI PMC

Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, et al. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017; 2(10):e473–82. 10.1016/S2468-2667(17)30157-3 PubMed DOI

Lucidarme J, Hill DM, Bratcher HB, Gray SJ, du Plessis M, Tsang RS, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015; 71(5):544–52. 10.1016/j.jinf.2015.07.007 PubMed DOI PMC

Lucidarme J, Scott KJ, Ure R, Smith A, Lindsay D, Stenmark B, et al. An international invasive meningococcal disease outbreak due to a novel and rapidly expanding serogroup W strain, Scotland and Sweden, July to August 2015. Euro Surveill. 2016; 21(45):pii30395 10.2807/1560-7917.ES.2016.21.45.30395 PubMed DOI PMC

Krizova P, Musilek M, Okonji Z, Honskus M, Kozakova J, Sebestova H. Invasive meningococcal disease in the Czech Republic in 2017. CEM Reports. 2018; 27(1):16–23. (in Czech language). Available: http://www.szu.cz/uploads/IMO/Zpravy_CEM_IMO_2017_2.pdf

The National Institute of Public Health, Czech Republic. Recommendations of the Czech Vaccinology Society of the J. E. Purkyně Czech Medical Association for vaccination against invasive meningococcal disease, 15th January 2018. Accessed 7 May 2019. Available: http://www.szu.cz/uploads/IMO/2018_Recommendation_for_vaccination_againts_IMD.pdf

No Act. 48/1997 Coll., On Public Health Insurance, as amended, §30 Reimbursed Preventive Care, Changes from 1 January 2018. (in Czech language). Available: http://szu.cz/tema/vakciny/ockovaci-kalendar-v-cr

Brehony C, Rodrigues CMC, Borrow R, Smith A, Cunney R, Moxon ER, et al. Distribution of Bexsero Antigen Sequence Types (BASTs) in invasive meningococcal disease isolates: Implications for immunisation. Vaccine. 2016; 34(39):4690–7. 10.1016/j.vaccine.2016.08.015 PubMed DOI PMC

Kesanopoulos K, Bratcher HB, Hong E, Xirogianni A, Papandreou A, Taha MK, et al. Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation. PLos One. 2018; 13(12):e0209919 10.1371/journal.pone.0209919 PubMed DOI PMC

Mulhall RM, Bennett D, Cunney R, Borrow R, Lucidarme J, Findlow J, et al. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B Neisseria meningitidis Isolated from 2009 to 2013 in the Republic of Ireland. mSphere. 2018; 3(4):e00196–18. 10.1128/mSphere.00196-18 PubMed DOI PMC

Rodrigues CMC, Lucidarme J, Borrow R, Smith A, Cameron JC, Moxon ER, et al. Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016. Emerg Infect Dis. 2018; 24(4):673–82. 10.3201/eid2404.171480 PubMed DOI PMC

Vackova Z, Krizova P, Jandova Z, Musilek M, Kozakova J. The possibilities for the implementation of whole genome sequencing (WGS) of Neisseria meningitidis in molecular surveillance of invasive meningococcal disease in the Czech Republic. Epidemiol Mikrobiol Imunol. 2017; 66(1):50–52. PubMed

Krizova P, Honskus M, Okonji Z, Musilek M, Kozakova J. Surveillance of invasive meningococcal disease based on whole genome sequencing (WGS), Czech Republic, 2015. Epidemiol Mikrobiol Imunol. 2018; 67(2):64–73. PubMed

Honskus M, Okonji Z, Musilek M, Kozakova J, Krizova P. Whole genome sequencing of Neisseria meningitidis W isolates from the Czech Republic recovered in 1984–2017. PLoS One. 2018; 13(9):e0199652 10.1371/journal.pone.0199652 PubMed DOI PMC

Zerbino DR. Using the Velvet de novo assembler for short-read sequencing technologies. Curr Protoc Bioinformatics. 2010; 11(5):1–12. 10.1002/0471250953.bi1105s31 PubMed DOI PMC

Maiden MCJ, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A. 1998; 95(6):3140–5. 10.1073/pnas.95.6.3140 PubMed DOI PMC

Nissen MD, Marshall HS, Richmond PC, Jiang Q, Harris SL, Jones TR, et al. A randomized, controlled, phase ½ trial of a Neisseria meningitidis serogroup B bivalent rLP2086 vaccine in a healthy children and adolescents. Pediatr Infect Dis J. 2013; 32(4):364–71. 10.1097/INF.0b013e31827b0d24 PubMed DOI

Vernikos G, Medini D. Bexsero chronicle. Pathog Glob Health. 2014; 108(7):305–16. 10.1179/2047773214Y.0000000162 PubMed DOI PMC

Bambini S, De Chiara M, Muzzi A, Mora M, Lucidarme J, Brehony C, et al. Neisseria adhesin A variation and revised nomenclature scheme. Clin Vaccine Immunol. 2014; 21(7):966–71. 10.1128/CVI.00825-13 PubMed DOI PMC

Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, Arico B, et al. Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med. 2003; 197(6)789–99. 10.1084/jem.20021911 PubMed DOI PMC

Serruto D, Spadafina T, Ciucchi L, Lewis LA, Ram S, Tontini M, et al. Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans. Proc Natl Acad Sci U S A. 2010; 107(8):3770–5. 10.1073/pnas.0915162107 PubMed DOI PMC

Jolley KA, Maiden MCJ. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics. 2010; 11:595 10.1186/1471-2105-11-595 PubMed DOI PMC

Bratcher HB, Corton C, Jolley KA, Parkhill J, Maiden MCJ. A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics. 2014; 15(1):1138 10.1186/1471-2164-15-1138 PubMed DOI PMC

Huson DH. SplitsTree: analyzing and visualizing evolutionary data. Bioinformatics. 1998; 14(1):68–73. 10.1093/bioinformatics/14.1.68 PubMed DOI

Hong E, Barret AS, Terrade A, Denizon M, Antona D, Aouiti-Trabelsi M, et al. Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France. J Infect. 2018; 76(2):149–58. 10.1016/j.jinf.2017.10.015 PubMed DOI

Lucidarme J, Lekshmi A, Parikh SR, Bray JE, Hill DM, Bratcher HB, et al. Frequent capsule switching in 'ultra-virulent' meningococci—Are we ready for a serogroup B ST-11 complex outbreak?. J Infect. 2017; 75(2):95–103. 10.1016/j.jinf.2017.05.015 PubMed DOI PMC

Fazio C, Neri A, Vacca P, Ciammaruconi A, Arghittu M, Barbui AM, et al. Cocirculation of Hajj and non-Hajj strains among serogroup W meningococci in Italy, 2000 to 2016. Euro Surveill. 2019; 24(4). 10.2807/1560-7917.ES.2019.24.4.1800183 PubMed DOI PMC

Vogel U, Claus H, Frosch M, Caugant DA. Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol. 2000; 38(2):941–2. PubMed PMC

Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis. 2013; 13(5):416–25. 10.1016/S1473-3099(13)70006-9 PubMed DOI

McNeil LK, Donald RGK, Gribenko A, French R, Lambert N, Harris SL, et al. Predicting the Susceptibility of Meningococcal Serogroup B Isolates to Bactericidal Antibodies Elicited by Bivalent rLP2086, a Novel Prophylactic Vaccine. MBio. 2018; 9(2):e00036–18. 10.1128/mBio.00036-18 PubMed DOI PMC

Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, et al. Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide. Vaccine. Forthcoming 2019. 10.1016/j.vaccine.2018.12.061 PubMed DOI

Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018; 3:124 10.12688/wellcomeopenres.14826.1 PubMed DOI PMC

Whole genome analysis of Neisseria meningitidis isolates from invasive meningococcal disease collected in the Czech Republic over 28 years (1993-2020)

Whole genome sequencing of Neisseria meningitidis Y isolates collected in the Czech Republic in 1993-2018